Vol. 36 No. 1 (2019)

Published: 21-03-2019

  • Everyday cognitive failure in patients suffering from neurosarcoidosis Cognitive failure in neurosarcoidosis

    DOI: https://doi.org/10.36141/svdld.v36i1.7412
    Mareye Voortman, Jolanda de Vries, Celine M.R. Hendriks, Marjon D.P. Elfferich, Petal A.H.M. Wijnen, Marjolein Drent
    2-10
  • Diagnostic approach for cardiac involvement in sarcoidosis

    DOI: https://doi.org/10.36141/svdld.v36i1.7132
    Pernilla Darlington, Anders Gabrielsen, Kerstin Cederlund, Susanna Kullberg, Johan Grunewald, Anders Eklund, Peder Sorensson
    11-17
  • Sensitivity and specificity of chest imaging for sarcoidosis screening in patients with cardiac presentations

    DOI: https://doi.org/10.36141/svdld.v36i1.6865
    Juan J Russo, Pablo B Nery, Andrew C Ha, Jeff S Healey, Daniel Juneau, Lena Rivard, Matthias G Friedrich, Lorne Gula, Gerald Wisenberg, Robert deKemp, Santabhanu Chakrabarti, Tomasz W Hruczkowski, Russell Quinn, F. Daniel Ramirez, Girish Dwivedi, Rob SB Beanlands, David H Birnie
    18-24
  • Neurosarcoidosis in a public safety net hospital: a study of 82 cases

    DOI: https://doi.org/10.36141/svdld.v36i1.7106
    James Dorman, Lakshmi Warrior, Vishal Pandya, Ying Sun, Jacob Ninan, William Trick, Helen Zhang, Bichun Ouyang
    25-32
  • Diagnostic management of occult nodal lymphangioleiomyomatosis detected during pelvic cancer staging. Localized finding or systemic disease?

    DOI: https://doi.org/10.36141/svdld.v36i1.7110
    Andrea Remo, Caterina Zanella, Pietro Parcesepe, Filippo Greco, Massimo Pancione, Mara Maria Zapparoli, Erminia Manfrin, Claudio Micheletto
    33-38
  • Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome

    DOI: https://doi.org/10.36141/svdld.v36i1.7117
    Ryo Okuda, Eri Hagiwara, Takuma Katano, Satoshi Ikeda, Akimasa Sekine, Hideya Kitamura, Tomohisa Baba, Koji Okudela, Kenichi Ohashi, Takashi Ogura
    39-46
  • Diffuse alveolar hemorrhage: how relevant is etiology?

    DOI: https://doi.org/10.36141/svdld.v36i1.7160
    André Terras Alexandre, Artur Vale, Teresa Gomes
    47-52
  • The impact of skin involvement on the psychological well-being of patients with Sarcoidosis Skin involvement in sarcoidosis

    DOI: https://doi.org/10.36141/svdld.v36i1.7270
    Saif Aldeen AlRyalat, Lna Malkawi, Hana Abu-Hassan, Nosaiba Al-Ryalat
    53-59
  • Musculoskeletal and pulmonary outcomes of sarcoidosis after initial presentation of osseous involvement

    DOI: https://doi.org/10.36141/svdld.v36i1.7326
    Ezra Ross Miller, Christopher H Fanta, Jakob I McSparron, Beatrice Pan, Jonathan S Coblyn, Jeffrey A Sparks
    60-73
  • Association of low body surface area with dose reduction and/or discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: a pilot study BSA and nintedanib reduction/discontinuation

    DOI: https://doi.org/10.36141/svdld.v36i1.7383
    Yukihiro Toi, Yuichiro Kimura, Yutaka Domeki, Sachiko Kawana, Tomoiki Aiba, Hirotaka Ono, Mari Asou, Kyoji Tsurumi, Kana Suzuki, Hisashi Shimizu, Jun Sugisaka, Ryohei Saito, Keisuke Terayama, Yosuke Kawashima, Atsushi Nakamura, Shinsuke Yamanda, Yoshihiro Honda, Shunichi Sugawara
    74-78

  • A case of relapsing isolated neurosarcoidosis in an 18-year-old male patient successfully treated by corticosteroids

    DOI: https://doi.org/10.36141/svdld.v36i1.7168
    Klaudia Kalmárová, Egon Kurča, Štefan Sivák, Jozef Michalik, Lukáš Plank, Róbert Vyšehradský, Kamil Zeleňák, Juraj Šutovský, Vladimir Nosáľ
    79-85

  • A composite score to assess treatment response in pulmonary sarcoidosis: the Sarcoidosis Treatment Score (STS)

    DOI: https://doi.org/10.36141/svdld.v36i1.7748
    Robert P. Baughman, Michael Tillinger, MTillinger, Yimin Qin, Nadera Sweiss, Elyse E Lower
    86-88
  • Sarcoidosis: an orphan disease needs to be adopted

    DOI: https://doi.org/10.36141/svdld.v36i1.6953
    Rashi Jain, Anant Mohan, Rinkee Kumari, Randeep Guleria
    89-90